
TCTMD
@tctmd
Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at tctmd.com
ID: 40042798
http://www.tctmd.com 14-05-2009 17:36:57
18,18K Tweet
27,27K Takipçi
6,6K Takip Edilen

DapaTAVI results, presented by Sergio Raposeiras-Roubín at #ACC25, find that high-risk TAVI patients have better outcomes when taking dapagliflozin. More from Raposeiras-Roubín, Wayne Batchelor, MD, and Dr. Deepak L. Bhatt here: bit.ly/4i7NKIX
